156 related articles for article (PubMed ID: 25608124)
1. Effect of speech therapy and pharmacological treatment in prosody of parkinsonians.
Azevedo LL; Souza IS; Oliveira PM; Cardoso F
Arq Neuropsiquiatr; 2015 Jan; 73(1):30-5. PubMed ID: 25608124
[TBL] [Abstract][Full Text] [Related]
2. Prosody and levodopa in Parkinson's disease.
Azevedo LL; Reis CA; Souza IS; Cardoso FE
Arq Neuropsiquiatr; 2013 Nov; 71(11):835-40. PubMed ID: 24394867
[TBL] [Abstract][Full Text] [Related]
3. [Speech and voice disorders in Parkinson's disease].
Martnez-Sánchez F
Rev Neurol; 2010 Nov; 51(9):542-50. PubMed ID: 20979034
[TBL] [Abstract][Full Text] [Related]
4. Levodopa-induced modifications of prosody and comprehensibility in advanced Parkinson's disease as perceived by professional listeners.
De Letter M; Santens P; Estercam I; Van Maele G; De Bodt M; Boon P; Van Borsel J
Clin Linguist Phon; 2007 Oct; 21(10):783-91. PubMed ID: 17882694
[TBL] [Abstract][Full Text] [Related]
5. For better or worse: The effect of levodopa on speech in Parkinson's disease.
Ho AK; Bradshaw JL; Iansek R
Mov Disord; 2008 Mar; 23(4):574-80. PubMed ID: 18163453
[TBL] [Abstract][Full Text] [Related]
6. Glottographic measures before and after levodopa treatment in Parkinson's disease.
Jiang J; Lin E; Wang J; Hanson DG
Laryngoscope; 1999 Aug; 109(8):1287-94. PubMed ID: 10443835
[TBL] [Abstract][Full Text] [Related]
7. Instability of syllable repetition in Parkinson's disease--influence of levodopa and deep brain stimulation.
Skodda S; Flasskamp A; Schlegel U
Mov Disord; 2011 Mar; 26(4):728-30. PubMed ID: 21506151
[TBL] [Abstract][Full Text] [Related]
8. Acoustic analysis of parkinsonian speech I: speech characteristics and L-Dopa therapy.
Goberman AM; Coelho C
NeuroRehabilitation; 2002; 17(3):237-46. PubMed ID: 12237505
[TBL] [Abstract][Full Text] [Related]
9. [Acoustic analysis of prosody in females with Parkinson's disease: effect of L-dopa].
Azevedo LL; Cardoso F; Reis C
Arq Neuropsiquiatr; 2003 Dec; 61(4):995-8. PubMed ID: 14762605
[TBL] [Abstract][Full Text] [Related]
10. Intonation and speech rate in Parkinson's disease: general and dynamic aspects and responsiveness to levodopa admission.
Skodda S; Grönheit W; Schlegel U
J Voice; 2011 Jul; 25(4):e199-205. PubMed ID: 21051196
[TBL] [Abstract][Full Text] [Related]
11. Effects of dopaminergic replacement therapy on motor speech disorders in Parkinson's disease: longitudinal follow-up study on previously untreated patients.
Rusz J; Tykalová T; Klempíř J; Čmejla R; Růžička E
J Neural Transm (Vienna); 2016 Apr; 123(4):379-87. PubMed ID: 26843071
[TBL] [Abstract][Full Text] [Related]
12. The effects of levodopa on word intelligibility in Parkinson's disease.
De Letter M; Santens P; Van Borsel J
J Commun Disord; 2005; 38(3):187-96. PubMed ID: 15748723
[TBL] [Abstract][Full Text] [Related]
13. The effect of levodopa on respiration and word intelligibility in people with advanced Parkinson's disease.
De Letter M; Santens P; De Bodt M; Van Maele G; Van Borsel J; Boon P
Clin Neurol Neurosurg; 2007 Jul; 109(6):495-500. PubMed ID: 17509751
[TBL] [Abstract][Full Text] [Related]
14. Pathomechanisms and compensatory efforts related to Parkinsonian speech.
Arnold C; Gehrig J; Gispert S; Seifried C; Kell CA
Neuroimage Clin; 2014; 4():82-97. PubMed ID: 24319656
[TBL] [Abstract][Full Text] [Related]
15. Parkinson's disease: speech and voice disorders and their treatment with the Lee Silverman Voice Treatment.
Ramig LO; Fox C; Sapir S
Semin Speech Lang; 2004 May; 25(2):169-80. PubMed ID: 15118943
[TBL] [Abstract][Full Text] [Related]
16. Levodopa-induced alterations in speech rate in advanced Parkinson's disease.
De Letter M; Santens P; De Bodt M; Boon P; Van Borsel J
Acta Neurol Belg; 2006 Mar; 106(1):19-22. PubMed ID: 16776432
[TBL] [Abstract][Full Text] [Related]
17. The effect of levodopa on the habituation of the acoustic-palpebral reflex in Parkinson's disease.
Rey RD; Garretto NS; Bueri JA; Simonetti DD; Sanz OP; Sica RE
Electromyogr Clin Neurophysiol; 1996 Sep; 36(6):357-60. PubMed ID: 8891475
[TBL] [Abstract][Full Text] [Related]
18. Effects of bilateral subthalamic nucleus stimulation and medication on parkinsonian speech impairment.
D'Alatri L; Paludetti G; Contarino MF; Galla S; Marchese MR; Bentivoglio AR
J Voice; 2008 May; 22(3):365-72. PubMed ID: 17368837
[TBL] [Abstract][Full Text] [Related]
19. The impact of Parkinson's disease on vocal-prosodic communication from the perspective of listeners.
Pell MD; Cheang HS; Leonard CL
Brain Lang; 2006 May; 97(2):123-34. PubMed ID: 16226803
[TBL] [Abstract][Full Text] [Related]
20. Sequential changes in motor speech across a levodopa cycle in advanced Parkinson's disease.
De Letter M; Van Borsel J; Boon P; De Bodt M; Dhooge I; Santens P
Int J Speech Lang Pathol; 2010 Oct; 12(5):405-13. PubMed ID: 20602581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]